Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR)

地址1 细胞外基质 小分子 化学 受体酪氨酸激酶 酪氨酸激酶 激酶 喹唑啉 癌症研究 细胞生物学 生物化学 药理学 受体 生物 立体化学
作者
Rohit Pal,B. Kumaraswamy,S. K. Md. Ashadul,Ketan R Hosamani,Gurubasavaraja Swamy Purawarga Matada
出处
期刊:ChemistrySelect [Wiley]
卷期号:9 (30) 被引量:4
标识
DOI:10.1002/slct.202401216
摘要

Abstract DDR1 and DDR2 are nonintegrin collagen receptors in the receptor tyrosine kinase family. Both DDRs bind to various collagen types and perform crucial functions in embryo development. DDRs are different from other receptor tyrosine kinases due to their interaction with extracellular matrix components and unusual activation kinetics. DDR regulates cell migration, survival, proliferation, differentiation, and extracellular matrix remodeling. Dysregulated DDR function is linked to the advancement of several human illnesses, including fibrosis, arthritis, neurodegenerative diseases, and cancer. DDRs play a vital role in disease progression and development. Therefore, the use of DDR inhibitors represents a promising therapeutic strategy, particularly for disorders with limited therapy alternatives. In recent years, DDRs have been regarded as attractive targets for drug development, as evidenced by a significant rise in research in this field. The current review illustrates about recent advancement of small molecules, their designing strategies and structure‐activity relationship. The DDR inhibitors can contain various core structures such as pyrimidine, phthalazine, pyrazole, pyrazine, imidazo[1,2‐ a ]sspyrazine, quinazoline, and thieno[3,2‐ b ]pyridin‐7‐yl derivatives. Furthermore, based on the constructive analysis of the published derivatives, we found that the majority of the powerful compounds have a similar scaffold (amide linker, hydrophobic tail, hinge binder with or without spacer). Among the different literature, the most potent compounds 4 ( imidazo[1,2‐ a ]pyrazine ) , 5 (pyridine), 19 (pyridine), and 24 (quinazoline) displayed potent activity against DDR1 with IC 50 values ranging from 2.26 – 4.67 nM, while DDR2 IC 50 values ranging from 3.2 – 7.29 nM. This approach will help medicinal chemists to refine and develop novel small molecules targeting DDR1 and DDR2.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
建议保存本图,每天支付宝扫一扫(相册选取)领红包
实时播报
gcy发布了新的文献求助10
1秒前
车访枫发布了新的文献求助10
1秒前
传奇3应助满集采纳,获得10
2秒前
唐雨欣完成签到,获得积分10
4秒前
LQ发布了新的文献求助10
4秒前
李健的小迷弟应助养乐多采纳,获得30
6秒前
热热完成签到 ,获得积分10
6秒前
大方的城完成签到,获得积分20
6秒前
草莓能宝宝完成签到 ,获得积分10
7秒前
8秒前
小马甲应助medaW采纳,获得10
8秒前
8秒前
lll完成签到,获得积分10
9秒前
情怀应助pipi采纳,获得10
9秒前
小蘑菇应助满意的一刀采纳,获得40
9秒前
10秒前
隐形曼青应助TGM_Hedwig采纳,获得10
10秒前
三月十六树完成签到 ,获得积分10
10秒前
11秒前
lurongjun完成签到,获得积分10
11秒前
12秒前
杨念一完成签到,获得积分10
12秒前
朱砂完成签到,获得积分10
12秒前
12秒前
灵巧夏青发布了新的文献求助20
13秒前
14秒前
suzy完成签到 ,获得积分10
14秒前
朱砂发布了新的文献求助30
15秒前
城南发布了新的文献求助10
16秒前
17秒前
敏感小熊猫完成签到,获得积分10
17秒前
xueshu666发布了新的文献求助50
17秒前
18秒前
浮游应助科研通管家采纳,获得10
18秒前
8R60d8应助科研通管家采纳,获得10
18秒前
传奇3应助科研通管家采纳,获得10
18秒前
科研通AI6应助科研通管家采纳,获得10
18秒前
脑洞疼应助科研通管家采纳,获得30
18秒前
LMY完成签到 ,获得积分10
19秒前
8R60d8应助科研通管家采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1041
Mentoring for Wellbeing in Schools 600
Binary Alloy Phase Diagrams, 2nd Edition 600
Atlas of Liver Pathology: A Pattern-Based Approach 500
A Technologist’s Guide to Performing Sleep Studies 500
EEG in Childhood Epilepsy: Initial Presentation & Long-Term Follow-Up 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5492371
求助须知:如何正确求助?哪些是违规求助? 4590495
关于积分的说明 14430692
捐赠科研通 4522967
什么是DOI,文献DOI怎么找? 2478089
邀请新用户注册赠送积分活动 1463151
关于科研通互助平台的介绍 1435822